Back to Treatments

Treatment

Delamanid-based Regimen (longer course)

1
Conditions
30
Trials
5,000
Participants
60%
Average Safety

Condition Evidence

Multidrug-resistant tuberculosis without extensive drug resistance

30 trials · 5,000 participants

78% effectiveness · 60% safety
Delamanid-based Regimen (longer course) | DFDA